Eli Lilly: Ebglyss To Challenge Dupixent In Atopic Dermatitis
Summary: Eli Lilly received FDA approval for Ebglyss for the treatment of moderate to severe
Summary: Eli Lilly received FDA approval for Ebglyss for the treatment of moderate to severe
da-kuk BTIG analysts refreshed their top fundamental stock picks for the second half of the
Carnival press release (NYSE:CCL): Q3 Non-GAAP EPS of $1.27 beats by $0.12. Revenue of $7.9B
Summary: Abercrombie & Fitch’s Q2 FY24 earnings beat estimates with 21% revenue growth and 95%
LeoPatrizi/E+ via Getty Images Apple (NASDAQ:AAPL) iPhone 16 delivery lead times have trended below historical
Summary: I am correcting my last ‘Sell’ view on NVIDIA; despite Q2 FY25’s result and
primeimages VZ shares are essentially flat in premarket trading. Stock is up +19% so far
Summary: Taiwan Semiconductor boasts a massive competitive moat due to its leadership in advanced chip
hapabapa Alphabet’s Google (NASDAQ:GOOG) (NASDAQ:GOOGL) has reached a multi-year deal with Malaysian technology firm Dagang